ScoreComparison
Why is Verrica Pharmaceuticals, Inc. ?
1
With a fall in Net Sales of -53.85%, the company declared Very Negative results in Jun 26
- The company has declared negative results in Jun 26 after 4 consecutive negative quarters
- NET SALES(Q) At USD 5.86 MM has Fallen at -53.85%
- OPERATING PROFIT MARGIN(Q) Lowest at -190.92 %
- NET PROFIT(Q) Lowest at USD -11.46 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 5.83%, its profits have risen by 74%
3
Underperformed the market in the last 1 year
- The stock has generated a return of 5.83% in the last 1 year, much lower than market (S&P 500) returns of 16.00%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Verrica Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Verrica Pharmaceuticals, Inc.
7.19%
-0.46
97.19%
S&P 500
15.76%
1.22
13.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
105.42%
EBIT Growth (5y)
11.23%
EBIT to Interest (avg)
-10.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.60
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
38.18%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.04
EV to EBIT
-3.84
EV to EBITDA
-4.11
EV to Capital Employed
-9.85
EV to Sales
1.29
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-76.79%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -13.46 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -217.97 %
-28What is not working for the Company
NET SALES(Q)
At USD 5.86 MM has Fallen at -53.85%
OPERATING PROFIT MARGIN(Q)
Lowest at -190.92 %
NET PROFIT(Q)
Lowest at USD -11.46 MM
RAW MATERIAL COST(Y)
Grown by 11.66% (YoY
CASH AND EQV(HY)
Lowest at USD 31.8 MM
OPERATING PROFIT(Q)
Lowest at USD -11.19 MM
PRE-TAX PROFIT(Q)
Lowest at USD -11.46 MM
EPS(Q)
Lowest at USD -0.62
Here's what is working for Verrica Pharmaceuticals, Inc.
Operating Cash Flow
Highest at USD -13.46 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at -217.97 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Verrica Pharmaceuticals, Inc.
Net Sales
At USD 5.86 MM has Fallen at -53.85%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -11.46 MM has Fallen at -2,807.36%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -11.46 MM has Fallen at -2,807.36%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit Margin
Lowest at -190.92 % and Fallen
In each period in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
Lowest at USD -11.46 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -11.19 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -11.46 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
EPS
Lowest at USD -0.62
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Cash and Eqv
Lowest at USD 31.8 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 11.66% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
